News
ASRT
--
0.00%
--
Field Roast's Chao Creamery Expands Dairy-Free Cheese Portfolio With Five New Varieties
Field Roast, the maker of the 1 selling plant-based cheese slice variety in U.S. retail, introduced 5 new dairy-free cheese flavors and forms.
Business Wire · 09/15 13:00
IDENTOS access control technology is part of an innovative $5.9 million federal investment for a health access platform
At launch, the TRUSTSPHERE platform will help connect families, caregivers and clinicians to improve patient-centered care for children with Type 1 diabetes at BC Children's Hospital, and improve the process to donate clinical data to research TORONTO, Sept. 9, 2020 /CNW/ - As part of the Digital
CNW Group · 09/09 14:30
Assertio to Present at Cantor Virtual Global Healthcare Conference on September 16, 2020
LAKE FOREST, Ill., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a commercial-stage pharmaceutical company, announced that the company will present at and participate in investor meetings at the Cantor Virtual Global Healthcare Conference. President
GlobeNewswire · 09/09 11:02
Government of Canada announces $2.5 million for Indigenous communities to address underwater vessel noise along the Trans Mountain shipping route
VANCOUVER, BC, Sept. 8, 2020 /CNW/ - The Government of Canada values the traditional knowledge and expertise of Canada's Indigenous peoples and coastal communities in protecting our coasts.
CNW Group · 09/08 17:13
Q&A-Why is China suspending imports from some meat processors?
Top meat importer China has suspended imports from some foreign meat packing plants where workers became infected with coronavirus - but not others. China is the world's top meat importer, bringing in huge volumes in recent months because of a shortfall at home. Authorities in Beijing found heavy
Reuters · 08/25 17:16
How Much Is Maple Leaf Foods Inc. (TSE:MFI) Paying Its CEO?
Michael McCain became the CEO of Maple Leaf Foods Inc. (TSE:MFI) in 1999, and we think it's a good time to look at the...
Simply Wall St. · 08/25 16:20
Lightlife® Makes a Clean Break from Plant-Based Competition, Commits to Delivering Simple, Delicious Food Developed in a Kitchen, Not a Lab
Lightlife® ("Lightlife"), owned by Greenleaf Foods, SPC, is making a clean break from its competition. The plant-based meat category is surging, with sales up 91% in the past year.1 Growing demand and research showing rising concern among consumers about the ingredients in their food have inspired
Business Wire · 08/25 10:00
Canada's Maple Leaf suspends pork exports to China amid COVID-19 outbreak at Manitoba plant
Reuters · 08/19 16:17
Maple Leaf Foods Provides Update on COVID-19 at Brandon Plant
Maple Leaf Foods Inc. (TSX: MFI) is continuing its rigorous safety efforts at its Brandon, Manitoba, plant to prevent workplace transmission amidst the recent COVID-19 cluster occurring in the community. The plant continues to operate safely, and Public Health experts have said on numerous occasions
PR Newswire · 08/19 01:59
Assertio Holdings, Inc. (ASRT) CEO Todd Smith on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 08/08 01:07
More on Assertio Therapeutics Q2 earnings
Assertio Therapeutics (ASRT -15.9%) Q2 GAAP EPS of -$0.35 missed consensus by $0.23. Combined Q2 pro-forma net product sales of $27.7M; Zyla net product sa
seekingalpha · 08/08 00:06
Assertio Therapeutics EPS misses by $0.23, misses on revenue
Assertio Therapeutics (NASDAQ:ASRT): Q2 GAAP EPS of -$0.35 misses by $0.23. Revenue of $20.62M (-64.0% Y/Y) misses by $4.71M. Shares +1% PM. Press Release
seekingalpha · 08/07 15:05
Assertio (ASRT) Reports Q2 Loss, Misses Revenue Estimates
Assertio (ASRT) delivered earnings and revenue surprises of -100.00% and -18.62%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/07 13:35
Recap: Assertio Holdings Q2 Earnings
Shares of Assertio Holdings (NASDAQ:ASRT) moved higher by 0.9% in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share were down 33.33% over the past year to ($0.28), which missed the estimate of ($0.03).Revenue of $20,
Benzinga · 08/07 11:23
Assertio Reports Second Quarter 2020 Financial Results
\--Completed all merger and integration activities in Q2-- \--Repaid $10 million of Senior Secured Notes ahead of schedule-- \--Zyla products partially contributed to Q2 net product sales of $20.2 million-- \--Combined second quarter 2020 net product sale
GlobeNewswire · 08/07 10:02
Preview: Assertio Therapeutics's Earnings
Assertio Therapeutics (NASDAQ: ASRT) will be releasing its next round of earnings this Friday, August 07. For all of the relevant information, here is your guide for Friday's Q2 earnings announcement.Earnings and Revenue Wall Street expects an EPS loss $-0.03
Benzinga · 08/06 19:50
Analysts Estimate Assertio (ASRT) to Report a Decline in Earnings: What to Look Out for
Assertio (ASRT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/31 16:30
Maple Leaf Foods Reports Second Quarter 2020 Financial Results
TSX: MFI www.mapleleaffoods.
CNW Group · 07/30 10:30
Maple Leaf Foods Closes Sale of Drummondville Poultry Plant to Giannone Poultry
MISSISSAUGA, ON, July 28, 2020 /CNW/ - Maple Leaf Foods Inc., (TSX: MFI) today announced that it has completed the previously announced sale of its poultry plant in Drummondville, Quebec, including the associated supply, to Giannone Poultry of St.
CNW Group · 07/28 20:30
Assertio to Release Second Quarter 2020 Financial Results and Host Webcast on August 7, 2020
LAKE FOREST, Ill., July 20, 2020 -- Assertio Holdings, Inc. (“Assertio”) (Nasdaq: ASRT), a commercial-stage pharmaceutical company, today announced that its second quarter 2020.
GlobeNewswire · 07/20 10:02
Webull provides a variety of real-time ASRT stock news. You can receive the latest news about Assertio Therapeutics through multiple platforms. This information may help you make smarter investment decisions.
About ASRT
Assertio Holdings, Inc. is a specialty pharmaceutical company. The Company owns a portfolio of prescription neurology, inflammation and pain medications. Its marketed products include Cambia (diclofenac potassium) for Oral solution, INDOCIN Oral Suspension, INDOCIN (indomethacin) Suppositories, OXAYDO tablets, SPRIX Nasal Spray, VIVLODEX capsules, ZIPSOR Liquid filled capsules and ZORVOLEX capsules. The Company is also focused on developing and commercializing neurology, orphan and specialty medicines. Its pipeline products include Diclofenac Potassium, Long-acting Cosyntropin and Diclofenac potassium. Diclofenac Potassium is being developed for mild/moderate acute pain. Long-acting Cosyntropin is being developed for diagnosis of adrenal insufficiency. Diclofenac potassium is a liquid formulation being developed for acute migraine attacks.
More